国际标准期刊号: 2155-952X

生物技术与生物材料

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 研究圣经
  • 中国知网(CNKI)
  • 访问全球在线农业研究 (AGORA)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Advanced novel flow cytometry applications

Oscar Fornas

Over time, flow cytometry has undergone a constant transformation. Current equipment is capable to detect more than 30 parameters simultaneously from each studied particle in suspension. The analysis can be performed at high speed, reaching up to 30,000 particles per second, in some cases even more. Consequently, flow cytometry is currently one of the most powerful technology for cell analysis. Within conventional applications, the one that has evolved most in recent years is the immunophenotyping. Currently, highdimensional flow cytometry analysis allows as to address multiparametric cell-analysis to elucidate most complex phenotypes.
On the other hand, lots of efforts are focused to develop new flow cytometry strategies and applications to address any biological question. We are currently focused on developing strategies that allow us to exceed the theoretical resolution limit of existing equipment. Recently, we have developed strategies to detect single Nano-sized particles (such as viruses, extracellular vesicles or chromosomes) of interest to the scientific community. Our new applications allow us to: 1- Identify virus at single-particle level and isolate them individually to study / discover new existing viruses and thus elucidate the global viriosphere, as part of the study of the global microbiome. 2- Identify and isolate EVs from different origins in the search for new biomarkers associated with pathologies of interest. 3- Finally, we have adapted the sorting of chromosomes to their subsequent sequencing without amplification to give light to some "dark zones" of known genomes that to date have low resolution in sequencing .